Close

Zymo Research has teamed up with Burst Diagnostics to launch a first-in-class diagnostic platform

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Senate Draft Cuts to Medicaid and CHIP Criticized

The American Medical Association has spoken out against the...

Alterations In US Healthcare System Likely in Trump 2.0

Apparently, there is one of the analysts who has...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first...

Low-Carbon Inhalers Approved for COPD Treatment in the UK

According to AstraZeneca, the Medicines and Healthcare Products Regulatory...

This partnership will transform the point-of-care diagnostics industry with faster, more precise detection of biomarkers, ultimately revolutionising healthcare.

Zymo Research will provide Burst Diagnostics with the necessary tools to enhance their platform, achieving unprecedented sensitivity and multiplexing capabilities in antigen-based point-of-care testing not seen before in the market.

The tests developed are simple, convenient, and inexpensive like rapid antigen tests but capable of producing laboratory-quality data with the level of sensitivity and accuracy previously exclusive to central lab run tests.

The creation of this advanced and ultra-sensitive technology will transform the industry and significantly impact the healthcare sector. It will enable faster and more precise diagnosis and treatment of diseases.

Latest stories

Related stories

Senate Draft Cuts to Medicaid and CHIP Criticized

The American Medical Association has spoken out against the...

Alterations In US Healthcare System Likely in Trump 2.0

Apparently, there is one of the analysts who has...

China’s AI Doctors Revolutionize Healthcare with First AI Hospital

China recently announced a ground-breaking development: the world's first...

Low-Carbon Inhalers Approved for COPD Treatment in the UK

According to AstraZeneca, the Medicines and Healthcare Products Regulatory...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back